CD86 and myeloid sarcoma: The expression of a B cell marker (CD19), pro-inflammatory cytokines (IL1B, IL6, and TNF), and CD86 (a costimulatory cell marker) in the PBMCs of 80 MS patients and 34 matched healthy controls was analyzed.